Literature DB >> 24132599

Detecting hepatocellular carcinoma in gadoxetic-acid-enhanced hepatobiliary-phase MR imaging at 3T: comparing high and low flip angle.

Mina Song1, Hyeon Je Cho, Yun Ku Cho, Mi Young Kim, Sang Ik Noh, Soo Hyun Yang.   

Abstract

PURPOSE: We evaluated the diagnostic performance of fat-suppressed 3D T1-weighted gradient-echo magnetic resonance imaging (MRI) sequences for the hepatobiliary phase of gadoxetic-acid-enhanced liver MRI between low and high flip angle (FA) at 3T.
MATERIALS AND METHODS: Forty-six patients with 62 HCCs were enrolled in this retrospective study from among 267 consecutive patients who underwent 3T MRI with low and high FA (10° and 25°) sequences at the hepatobiliary phase. A radiologist measured signal intensities and standard deviations (SD) of lesion, liver, and spleen and calculated signal-to-noise ratio, liver-spleen contrast, and liver-lesion contrast. Two reviewers assessed both image sequences using a five-point rating scale focusing on detecting hypointense lesions.
RESULTS: The high FA sequence showed significantly higher liver-spleen and liver-lesion contrast compared with those of low FA (p < 0.05, p < 0.05, respectively). Per-lesion sensitivities of high FA were higher than those of low FA (p < 0.05, p < 0.05, respectively), and per-person sensitivities were elevated on high FA (p < 0.05 in a reviewer). There were statistically significant differences for detecting HCCs larger than 1 cm (p < 0.05, p < 0.05, respectively).
CONCLUSION: Increasing FA in T1-weighted hepatobiliary-phase liver MRI may help in detecting HCC at 3T.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24132599     DOI: 10.1007/s11604-013-0255-z

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  30 in total

1.  Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA.

Authors:  G Jung; J Breuer; L W Poll; J A Koch; T Balzer; S Chang; U Mödder
Journal:  Acta Radiol       Date:  2006-02       Impact factor: 1.990

2.  High spatial resolution T1-weighted MR imaging of liver and biliary tract during uptake phase of a hepatocyte-specific contrast medium.

Authors:  Patrick Asbach; Carsten Warmuth; Alto Stemmer; Matthias Rief; Alexander Huppertz; Bernd Hamm; Matthias Taupitz; Christian Klessen
Journal:  Invest Radiol       Date:  2008-11       Impact factor: 6.016

3.  Flip angle modulations in late phase Gd-EOB-DTPA MRI improve the identification of the biliary system.

Authors:  Lars Stelter; Christian Grieser; Carmen Maria Pérez Fernándes; Jan Holger Rothe; Florian Streitparth; Daniel Seehofer; Bernd Hamm; Timm Denecke
Journal:  Eur J Radiol       Date:  2012-08-11       Impact factor: 3.528

4.  Hypointense hepatocellular nodules on hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI: can increasing the flip angle improve conspicuity of lesions?

Authors:  Tsutomu Tamada; Katsuyoshi Ito; Akira Yamamoto; Kazuya Yasokawa; Atsushi Higaki; Akihiko Kanki; Tomohiro Sato; Daigo Tanimoto; Hiroki Higashi
Journal:  J Magn Reson Imaging       Date:  2012-11-12       Impact factor: 4.813

5.  Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.

Authors:  Akira Yamada; Takeshi Hara; Feng Li; Yasunari Fujinaga; Kazuhiko Ueda; Masumi Kadoya; Kunio Doi
Journal:  Radiology       Date:  2011-06-28       Impact factor: 11.105

6.  Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers.

Authors:  Tsutomu Tamada; Katsuyoshi Ito; Atsushi Higaki; Koji Yoshida; Akihiko Kanki; Tomohiro Sato; Hiroki Higashi; Teruki Sone
Journal:  Eur J Radiol       Date:  2011-02-18       Impact factor: 3.528

Review 7.  Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.

Authors:  Kristina I Ringe; Daniela B Husarik; Claude B Sirlin; Elmar M Merkle
Journal:  AJR Am J Roentgenol       Date:  2010-07       Impact factor: 3.959

8.  Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.

Authors:  Sung Soo Ahn; Myeong-Jin Kim; Joon Seok Lim; Hye-Suk Hong; Yong Eun Chung; Jin-Young Choi
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

9.  Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.

Authors:  Bernd B Frericks; Christoph Loddenkemper; Alexander Huppertz; Steffi Valdeig; Andrea Stroux; Marion Seja; Karl-Jürgen Wolf; Thomas Albrecht
Journal:  AJR Am J Roentgenol       Date:  2009-10       Impact factor: 3.959

10.  The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.

Authors:  Jung Im Kim; Jeong Min Lee; Jin Young Choi; Young Kon Kim; Se Hyung Kim; Jae Young Lee; Joon Koo Han; Byung Ihn Choi
Journal:  Invest Radiol       Date:  2008-03       Impact factor: 6.016

View more
  1 in total

1.  Diagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference Standard.

Authors:  Eduardo A C Costa; Guilherme M Cunha; Emmanuil Smorodinsky; Irene Cruite; An Tang; Robert M Marks; Lisa Clark; Tanya Wolfson; Anthony Gamst; Jason K Sicklick; Alan Hemming; Michael R Peterson; Michael S Middleton; Claude B Sirlin
Journal:  Radiology       Date:  2015-04-15       Impact factor: 11.105

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.